Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hachulla

Showing results (431-440 of 506) with videos related to

Pageof 51
Sort By:
Rheumatology (Oxford, England)|December 19, 2024
Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional studyAlice Tison, Sandrine Jousse-Joulin, Maëlys Consigny, et al.
Autoimmunity Reviews|January 14, 2020
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosisVanessa Smith, Ariane L Herrick, Francesca Ingegnoli, et al.
Arthritis Research & Therapy|February 22, 2012
Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research groupChingching Foocharoen, Alan Tyndall, Eric Hachulla, et al.
Annals of Internal Medicine|June 2, 2020
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized TrialPierre Charles, Élodie Perrodeau, Maxime Samson, et al.
Annals of the Rheumatic Diseases|April 18, 2020
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trialDinesh Khanna, Yannick Allanore, Christopher P Denton, et al.
Rheumatology (Oxford, England)|March 9, 2024
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosisDinesh Khanna, Frank Kramer, Josef Höfler, et al.
Clinical Pharmacology and Therapeutics|September 20, 2017
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered QuestionnairesNathalie Costedoat-Chalumeau, Frédéric Houssiau, Peter Izmirly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2022
High Frequency of Specific Polysaccharide Antibody Deficiency in Adults With Unexplained, Recurrent and/or Severe Infections With Encapsulated BacteriaSarah Stabler, Catherine Lamblin, Sacha Gaillard, et al.
Seminars in Arthritis and Rheumatism|December 18, 2025
Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort studyKevin Chevalier, Brigitte Bader-Meunier, Isabelle Kone-Paut, et al.
Medicine|March 18, 2016
Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase DeficiencyCécile-Audrey Durel, Achille Aouba, Boris Bienvenu, et al.
Pageof 51

Showing results (431-440 of 506) with videos related to

Sort By:
Pageof 51
Rheumatology (Oxford, England)|December 19, 2024
Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional studyAlice Tison, Sandrine Jousse-Joulin, Maëlys Consigny, et al.
Autoimmunity Reviews|January 14, 2020
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosisVanessa Smith, Ariane L Herrick, Francesca Ingegnoli, et al.
Arthritis Research & Therapy|February 22, 2012
Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research groupChingching Foocharoen, Alan Tyndall, Eric Hachulla, et al.
Annals of Internal Medicine|June 2, 2020
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized TrialPierre Charles, Élodie Perrodeau, Maxime Samson, et al.
Annals of the Rheumatic Diseases|April 18, 2020
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trialDinesh Khanna, Yannick Allanore, Christopher P Denton, et al.
Rheumatology (Oxford, England)|March 9, 2024
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosisDinesh Khanna, Frank Kramer, Josef Höfler, et al.
Clinical Pharmacology and Therapeutics|September 20, 2017
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered QuestionnairesNathalie Costedoat-Chalumeau, Frédéric Houssiau, Peter Izmirly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2022
High Frequency of Specific Polysaccharide Antibody Deficiency in Adults With Unexplained, Recurrent and/or Severe Infections With Encapsulated BacteriaSarah Stabler, Catherine Lamblin, Sacha Gaillard, et al.
Seminars in Arthritis and Rheumatism|December 18, 2025
Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort studyKevin Chevalier, Brigitte Bader-Meunier, Isabelle Kone-Paut, et al.
Medicine|March 18, 2016
Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase DeficiencyCécile-Audrey Durel, Achille Aouba, Boris Bienvenu, et al.
Pageof 51